GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PACB · Jun 30, 2025

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001299130-25-000156General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.38% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-73.87% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

10.42% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

135.39% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

36.93% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-112.79% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

56.65% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

29.91% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History8 statesHistory building

Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20250/8 normalizedLevel 3 Mar 31, 20260/8 normalizedLevel 3 Jun 30, 20260/8 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 3.74%
Current: 1.38%
Delta: -2.36%

Cash Generation Increased

Previous: -118.58%
Current: -73.87%
Delta: 44.71%

Growth Increased

Previous: -4.27%
Current: 10.42%
Delta: 14.69%

Inventory Pressure Decreased

Previous: 145.36%
Current: 135.39%
Delta: -9.97%

Margin Increased

Previous: -3.69%
Current: 36.93%
Delta: 40.62%

Profitability Increased

Previous: -1154.51%
Current: -112.79%
Delta: 1041.71%

R And D Intensity Decreased

Previous: 78.20%
Current: 56.65%
Delta: -21.54%

Sbc Intensity Increased

Previous: 24.77%
Current: 29.91%
Delta: 5.15%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · PACB Fundamental State →Has State · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. →Transitioned To · PACB Fundamental State →Transitioned To · PACB CAPEX_INTENSITY_DECREASED →Transitioned To · PACB CASH_GENERATION_INCREASED →Transitioned To · PACB GROWTH_INCREASED →Transitioned To · PACB INVENTORY_PRESSURE_DECREASED →Transitioned To · PACB MARGIN_INCREASED →Transitioned To · PACB PROFITABILITY_INCREASED →Transitioned To · PACB R_AND_D_INTENSITY_DECREASED →Transitioned To · PACB SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.